Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

Fig. 1

Isolation and characterization of clonogenic and proliferative potential of WJ-MSCs and AM-MSCs. a Morphologies of WJ-MSCs and AM-MSCs observed under inverted microscopy. b Representative images showing the colony number and a single clone of CFU-Fs observed from WJ-MSCs and AM-MSCs. c Cumulative CFU-F numbers of WJ-MSCs and AM-MSCs. d Proliferation and metabolism of WJ-MSCs and AM-MSCs as investigated by the MTT assay. (c and d) Mean ± SD of five independent donors. * P < 0.001, significant difference between the two cell sources (CFU-F and MTT assays at the same time point). AM-MSCs amniotic membrane mesenchymal stem cells, CFU-F colony-forming unit fibroblast, WJ-MSCs Wharton’s jelly mesenchymal stem cells

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512